Answers are grounded in this paper and cite their sources.
Topical ocular hypotensive medication was effective in delaying or preventing the onset of POAG in individuals with elevated IOP. Although this does not imply that all patients with borderline or elevated IOP should receive medication, clinicians should consider initiating treatment for individuals with ocular hypertension who are at moderate or high risk for developing POAG.
No takes yet. Share an insight, caveat, or question.
Michael A. Kass (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: